Results 61 to 70 of about 249,781 (322)

Comparative results of repair of Ischemic Mitral Regurgitation (IMR): Conventional against Trans-Septal Approach

open access: yesInternational Journal of Endorsing Health Science Research, 2017
Objective: Ischemic mitral regurgitation is common and increases mortality, even when mild. (American Heart Association) AHA and European association have both stressed the need of mitral valve repair in patients with moderate or more regurgitation.
Ahson Memon   +6 more
doaj   +1 more source

Prophylactic IABP Use in Protected PCI Reduces Infarction Size and Leads to More Complete Revascularization in Comparison to Rescue IAPB Use

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background There is little data questioning the timing of intra‐aortic balloon pump (IABP) implantation in non‐cardiogenic shock patients undergoing high‐risk percutaneous procedures. Aims We compared prophylactic IABP (P‐IABP) implantation to an emergent, unplanned rescue use (R‐IABP) in high‐risk PCI. Methods Among 300 IAPB patients who were
Sascha d'Almeida   +8 more
wiley   +1 more source

Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging

open access: yesNature Reviews Cardiology, 2019
Mitral regurgitation (MR) is a common valvular heart disease and is the second most frequent indication for heart valve surgery in Western countries. Echocardiography is the recommended first-line test for the assessment of valvular heart disease, but ...
P. Garg   +9 more
semanticscholar   +1 more source

Biomarkers in Mitral Regurgitation

open access: yesProgress in Cardiovascular Diseases, 2017
Mitral regurgitation (MR) is a common cause of heart failure but may also remain silent without either symptoms or altered cardiac function. In the latter case, management is still controversial and biomarkers could be an important means to solving remaining issues in MR management.
Marie-Annick Clavel   +3 more
openaire   +3 more sources

Impact of Mitral Regurgitation Recurrence on Mitral Valve Repair for Secondary Ischemic Mitral Regurgitation

open access: yesJournal of Cardiovascular Development and Disease, 2023
Objectives. The current guidelines still do not include specific recommendations on the use of subvalvular repair (SV-r) for treatment of ischemic mitral regurgitation (IMR). Therefore, the objective of our study was to evaluate the clinical impact of mitral regurgitation (MR) recurrence and ventricular remodeling on long-term outcomes after SV-r ...
Salsano, Antonio   +8 more
openaire   +6 more sources

Early Stroke Volume Variation After Transcatheter or Surgical Aortic Valve Replacement Predicts Clinical Outcomes in Low‐Flow Aortic Stenosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Little is known about stroke volume index (SVi) change and its prognostic implication in patients with low‐flow aortic stenosis (AS) undergoing aortic valve replacement (AVR) and conflicting results are present in literature. The aim of this study was to evaluate the postoperative change in SVi and its impact on outcomes in patients
Giorgio Fiore   +14 more
wiley   +1 more source

Mitral Regurgitation

open access: yesJACC Case Reports, 2022
M. Enriquez-Sarano   +4 more
semanticscholar   +2 more sources

Wong's anomaly – A rare variant of cor triatriatum

open access: yesIndian Heart Journal, 2015
Cor triatriatum sinistrum is an extremely rare congenital heart disease. It is even more uncommon in adults, and clinically significant mitral valve lesion complicating cor triatriatum is distinctly rare.
K. Jayaprakash   +5 more
doaj   +1 more source

Advent of severe mitral regurgitation in surgical ventricular restoration and ventricular septal rupture repair

open access: yesBMC Cardiovascular Disorders, 2023
Background Per-procedural severe mitral regurgitation is a rare complication in concomitant surgical ventricular restoration and postinfarction ventricular septal rupture repair.
Yihua Liu   +7 more
doaj   +1 more source

Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years

open access: yesEuropean Journal of Heart Failure, 2019
The MITRA‐FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for heart failure at 12 months compared with guideline‐directed medical ...
B. Iung   +30 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy